Close Menu

NEW YORK – Biocept filed a preliminary prospectus with the US Securities and Exchange Commission today for an offering of $13.8 million in shares of its common stock, coupled with warrants to purchase additional shares.

The company has not yet priced the offering but said that each stock share will come with a warrant to purchase one additional share. Warrants will be immediately exercisable and will expire on the fifth anniversary of the original issuance date.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.